课题基金 / 基金详情

Phamracological and molecular biological analyzes on regulatory mechanisms for neurotransmitter receptor expression

Phamracological and molecular biological analyzes on regulatory mechanisms for neurotransmitter receptor expression
神经递质受体表达调控机制的药理学和分子生物学分析
批准号:
08557147
负责人:
OHKUMA Seitaro
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

OHKUMA Seitaro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Regulatory mechanisms for exoression of neurotransmitter receptors, especially beta-adrenergic receptors ( beta-AR), were investigated by measuring [^3H] CGP-12177 binding to the particulate fraction from mouse cerebral cortical neurons and mRNAs of beta1-and beta2-AR in neurons exposed to nadolol, an antagonist of beta-AR.Nadolol exposure induced rapid increase in the binding within 12 hrs and the binding attained its plateau after 24 hrs of the exposure. When measuring [^3H] CGP-12177 binding in the presence of each antagonist for beta2-and beta1-AR,the bindings significantly increased, indicating that the bindings to both beta1-and beta2-AR increased. Scatchard analysis revealed that this increase in the binding was due to Bmax balue without any changes in Kd value. mRNAs for both beta-AR subtypes increased significantly 24 hrs after the exposure, suggesting two distinct processers, increasing processer of receptor number with and without increase in mRNA.After 15 min and 1 hr of the exposure significant and transient increases in zif286 and c-fos mRNAs were observed. Induction of antisense for zif286 into the neurons before the exposure to nadolol abolished nadolol-induced increase in [^3H] CGP-12177 binding. These results indicate that the expression of zif286 plays a significant role in the expression of beta-AR upregulation. Inaddition, released of GABA release mechanisms by nitric oxide (NO) were investigated. Both materials induced increases in GABA release both dependent on Ca^<2+> and independent of Ca^<2+>. The latter type of release was the reverse process of Na^+-dependent GABA transport system. The increased influx Ca^<2+> of by NO is clarified to be caused by activation of L-and P/Q-typed voltage-dependent Ca^<2+> channels.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
大熊誠太郎他: "最新の伝達物質一受容体の分子機構と関連神経疾患" メジカルビュー社, 90-99 (1996)
Seitaro Okuma 等人:“递质受体和相关神经疾病的最新分子机制”Medical View Publishing,90-99 (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
大熊誠太郎 他: "NOラジカルの医学" 羊土社, 12 (1996)
Seitaro Okuma 等人:“NO Radical Medicine”Yodosha,12 (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katsura, M.et al.: "Peroxynitrite (OONO-) inhibits N-typed voltage-dependent Ca^<2+> channels (VDCCs)." Japan.J.Pharmacol.(in press). (1998)
Katsura, M.等人:“过氧亚硝酸盐 (OONO-) 抑制 N 型电压依赖性 Ca^2 通道 (VDCC)。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    An attempt to develop pharmacogenomic therapy and prevention of drug dependence.
    • 批准号:
      15390175
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2003
    • 负责人:
      OHKUMA Seitaro
    • 依托单位:
    β-Adrenoceptor up-regulation and intracellular signal transduction systems
    • 批准号:
      13670105
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.83万
    • 财政年份:
      2000
    • 负责人:
      OHKUMA Seitaro
    • 依托单位:
    Survey of peroxynitrite scavengers and its application for pathophysiolgy
    • 批准号:
      10557247
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $7.17万
    • 财政年份:
      1998
    • 负责人:
      OHKUMA Seitaro
    • 依托单位:
    Functional relationship between NMDA-induced neuronal injury and various neurotransmitter receptors
    • 批准号:
      04670127
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1992
    • 负责人:
      OHKUMA Seitaro
    • 依托单位:
    国内基金
    海外基金
    生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
    • 批准号:
      82371332
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      胡琴
    • 依托单位:
    脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
    • 批准号:
      82371223
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      闻大翔
    • 依托单位:
    基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
    • 批准号:
      82371373
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      沃雁
    • 依托单位:
    小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
    • 批准号:
      82371248
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      吴逸雯
    • 依托单位: